Jean‐Claude Debouzy
- Organic Chemistry top 5%
- Synthesis and Characterization of Heterocyclic Compounds 5
- Synthesis and Reactivity of Heterocycles 4
- Synthesis and Biological Evaluation 4
- Chemical synthesis and alkaloids 4
- Equine top 10%
-
- Electromagnetic Fields and Biological Effects 4
-
- Lipid Membrane Structure and Behavior 4
-
- Fibromyalgia and Chronic Fatigue Syndrome Research 3
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Alain GueiffierPatrick MassonFlorence FauvelleLawrence M. SchopferOksana LockridgeCécile Enguehard‐GueiffierJean‐Pierre ChapatFlorian Nachon
- Cited by
- Organic ChemistryEquineToxicology
- Journals
- European Journal of Medicinal Chemistry (2 papers)Toxicology (1 paper)FEBS Journal (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Jean‐Claude Debouzy
33 papers receiving 640 citations
Peers
Comparison fields: 5 of 93
- Organic Chemistry 326
- Equine 13
- Toxicology 16
- Pharmaceutical Science 27
- Pharmacology 74
Countries citing papers authored by Jean‐Claude Debouzy
This map shows the geographic impact of Jean‐Claude Debouzy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Debouzy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Debouzy more than expected).
Fields of papers citing papers by Jean‐Claude Debouzy
This network shows the impact of papers produced by Jean‐Claude Debouzy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Debouzy. The network helps show where Jean‐Claude Debouzy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐Claude Debouzy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2021 | 0 | |
| 3 | 2018 | 13 | |
| 4 | 2016 | 2 | |
| 5 | 2010 | 2 | |
| 6 | 2010 | 20 | |
| 7 | 2009 | 5 | |
| 8 | 2009 | 29 | |
| 9 | 2008 | 4 | |
| 10 | 2007 | 83 | |
| 11 | 2006 | 5 | |
| 12 | 2006 | 9 | |
| 13 | 2005 | 21 | |
| 14 | 2004 | 52 | |
| 15 | 2003 | 33 | |
| 16 | 2002 | 0 | |
| 17 | 2001 | 18 | |
| 18 | 1998 | 5 | |
| 19 | 1996 | 23 | |
| 20 | 1994 | 4 |
About Jean‐Claude Debouzy
Jean‐Claude Debouzy is a scholar working on Biophysics, Equine and Pharmaceutical Science, having authored 37 papers that have together received 654 indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (5 papers), Electromagnetic Fields and Biological Effects (4 papers), Synthesis and Reactivity of Heterocycles (4 papers), Synthesis and Biological Evaluation (4 papers), Lipid Membrane Structure and Behavior (4 papers), Chemical synthesis and alkaloids (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Organic Chemistry (326 citations), Equine (13 citations) and Toxicology (16 citations). Jean‐Claude Debouzy has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Alain Gueiffier, Patrick Masson, Florence Fauvelle, Lawrence M. Schopfer, Oksana Lockridge, Cécile Enguehard‐Gueiffier, Jean‐Pierre Chapat, Florian Nachon, David Crouzier and Olivier Chavignon. Their work appears in journals such as European Journal of Medicinal Chemistry, Toxicology, FEBS Journal, Journal of Cerebral Blood Flow & Metabolism and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.